TPTX : Turning Point Therapeutics stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 7 Wall Street analysts offering Turning Point Therapeutics stock forecast in the last 6 months have average price target of $136.43 with a high forecast of $190.0 and a low forecast of $116.0. The average Turning Point Therapeutics stock forecast represents a 72.81% increase from the last price of $78.95. From AI system, total return is 1951.0% from 1587 forecasts. For Turning Point Therapeutics stock forecast 2021, 8 predictions are offered for each month of 2021 with average Turning Point Therapeutics stock forecast of $77.57, a high forecast of $83.49, and a low forecast of $73.97. The average Turning Point Therapeutics stock forecast 2021 represents a -1.75% decrease from the last price of $78.95. For Turning Point Therapeutics stock forecast 2022, 12 predictions are offered for each month of 2022 with average Turning Point Therapeutics stock forecast of $93.47, a high forecast of $96.79, and a low forecast of $85.75. The average Turning Point Therapeutics stock forecast 2022 represents a 18.4% increase from the last price of $78.95. For Turning Point Therapeutics stock forecast 2025, 12 predictions are offered for each month of 2025 with average Turning Point Therapeutics stock forecast of $114.37, a high forecast of $115.23, and a low forecast of $113.37. The average Turning Point Therapeutics stock forecast 2025 represents a 44.86% increase from the last price of $78.95. For Turning Point Therapeutics stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Turning Point Therapeutics stock forecast of $115.23, a high forecast of $115.34, and a low forecast of $115.11. The average Turning Point Therapeutics stock forecast 2026 represents a 45.95% increase from the last price of $78.95. For Turning Point Therapeutics stock forecast 2030, 12 predictions are offered for each month of 2030 with average Turning Point Therapeutics stock forecast of $121.25, a high forecast of $123.65, and a low forecast of $117.85. The average Turning Point Therapeutics stock forecast 2030 represents a 53.57% increase from the last price of $78.95. For Turning Point Therapeutics stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Turning Point Therapeutics stock forecast of $121.37, a high forecast of $122.76, and a low forecast of $120.33. The average Turning Point Therapeutics stock forecast 2031 represents a 53.73% increase from the last price of $78.95. Please, see more forecasts below.